article thumbnail

Should You Bother Targeting the Tech Blogs for Your PR Campaigns?

Both Sides of the Table

6 or 7 years ago when TechCrunch was at its peak market share (they are still strong but many more tech blogs have also popped up) there was a term for getting covered there called “the TechCrunch bounce.” It’s also important for recruiting, fund raising, business development and even company morale.

Blogging 309
article thumbnail

Retro: My Favorite Blog Post on Raising VC

Both Sides of the Table

On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Painfully Poor Record of New Pain Drug Development: BIO Report

Xconomy

But the development of non-addictive, non-opioid pain drugs lags far behind drug R&D for other diseases ( I wrote a few months ago about why that is ), and a report from BIO released today helps quantify just how little the industry is doing in this area, and how rarely they succeed when companies do try.

Develop 73
article thumbnail

Entrepreneurshit. The Blog Post on What It’s Really Like.

Both Sides of the Table

The press who trusted me enough to report on our successes. Develop a thick skin for it. Despite the fact that only the Lotto winners get reported. ” Truthfully, that’s one of the things that kept me going. I didn’t want to disappoint. I didn’t want to disappoint my parents. My employees. Not fun, hey?

Blogging 420
article thumbnail

SPECIAL REPORT: 2019 Blockchain Outlook — Reality Check

Xconomy

Now, the industry has entered a crucial phase where blockchain developers need to overcome the limitations of the technology and find use cases that will win widespread adoption by businesses and organizations.

Report 98
article thumbnail

Advanced Therapies Are Reshaping Biopharma R&D: KPMG Report

Xconomy

The audit, tax, and advisory services firm shared details of the trend in its Healthcare & Life Sciences Outlook report, explaining that for companies developing cell, gene, and nucleic acid-based therapies, innovation is a necessity. “As KPMG says companies that choose to own the whole spectrum of R&D and manufacturing can.

Report 89
article thumbnail

New COVID-19 Special Reports Explore Clinical Research During the Pandemic

Xconomy

Two new special reports on Xconomy Insight provide an expert view on how companies can sustain clinical trials during the COVID-19 crisis.